EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes

Dakota Gustafson, Peter V DiStefano, Xue Fan Wang, Ruilin Wu, Siavash Ghaffari, Crizza Ching, Kumaragurubaran Rathnakumar, Faisal Alibhai, Michal Syonov, Jessica Fitzpatrick, Emilie Boudreau, Cori Lau und 7 weitere

Diabetologia · 2024

DOI: 10.1007/s00125-024-06120-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetologia, 2024. Verfasst von Dakota Gustafson und 18 weiteren Autor:innen. Beteiligte Einrichtung: Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Extracellular Vesicles, Diabetes Mellitus, Type 2, Capillary Permeability. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Vascular Network, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims/hypothesis A hallmark chronic complication of type 2 diabetes mellitus is vascular hyperpermeability, which encompasses dysfunction of the cerebrovascular endothelium and the subsequent development of associated cognitive impairment. The present study tested the hypothesis that during type 2 diabetes circulating small extracellular vesicles (sEVs) exhibit phenotypic changes that facilitate pathogenic disruption of the vascular barrier. Methods sEVs isolated from the plasma of a mouse model of type 2 diabetes and from diabetic human individuals were characterised for their ability to disrupt the endothelial cell (EC) barrier. The contents of sEVs and their effect on recipient ECs were assessed by proteomics and identified pathways were functionally interrogated with small molecule inhibitors. Results Using intravital imaging, we found that diabetic mice ( Lepr db/db ) displayed hyperpermeability of the cerebrovasculature. Enhanced vascular leakiness was recapitulated following i.v. injection of sEVs from diabetic mice into non-diabetic recipient mice. Characterisation of circulating sEV populations from the plasma of diabetic mice and humans demonstrated increased quantity and size of sEVs compared with those isolated from non-diabetic counterparts. Functional experiments revealed that sEVs from diabetic mice or humans induced the rapid and sustained disruption of the EC barrier through enhanced paracellular and transcellular leak but did not induce inflammation. Subsequent sEV proteome and recipient EC phospho-proteome analysis suggested that extracellular vesicles (sEVs) from diabetic mice and humans modulate the MAPK/MAPK kinase (MEK) and Rho-associated protein kinase (ROCK) pathways, cell–cell junctions and actin dynamics. This was confirmed experimentally. Treatment of sEVs with proteinase K or pre-treatment of recipient cells with MEK or ROCK inhibitors reduced the hyperpermeability-inducing effects of circulating sEVs in the diabetic state. Conclusions/interpretation Diabetes is associated with marked increases in the concentration and size of circulating sEVs. The modulation of sEV-associated proteins under diabetic conditions can induce vascular leak through activation of the MEK/ROCK pathway. These data identify a new paradigm by which diabetes can induce hyperpermeability and dysfunction of the cerebrovasculature and may implicate sEVs in the pathogenesis of cognitive decline during type 2 diabetes. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesDiabetes Mellitus, Type 2Capillary PermeabilityAnimalsMiceHumansMaleDiabetes Mellitus, ExperimentalEndothelial CellsEndothelium, VascularProteomicsMice, Inbred C57BL

Stichwörter der Autor:innen

CerebrovasculatureCognitive impairmentDiabetesEndothelial dysfunctionExtracellular vesiclesPermeabilityType 2 DiabetesVascular biologyVascular hyperpermeabilityVasculature

Autor:innen und Institutionen

  • Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
  • Division of Fundamental Neurobiology, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada.
  • Keenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, ON, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
  • Department of Medicine and Pediatrics, Women's College Hospital, Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.

Förderung

  • CIHR
  • Canadian Vascular Network
  • Canadian Institutes of Health Research
  • Canadian Cancer Society

Zitieren

APA

Gustafson, D., DiStefano, P. V., Wang, X. F., Wu, R., Ghaffari, S., Ching, C., Rathnakumar, K., Alibhai, F., Syonov, M., Fitzpatrick, J., Boudreau, E., Lau, C., Galant, N., Husain, M., Li, R. K., Lee, W. L., Parekh, R. S., Monnier, P. P., & Fish, J. E. (2024). Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes. Diabetologia. https://doi.org/10.1007/s00125-024-06120-9

Vancouver

Gustafson D, DiStefano PV, Wang XF, Wu R, Ghaffari S, Ching C, et al. Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes. Diabetologia. 2024. doi:10.1007/s00125-024-06120-9

BibTeX
@article{Gustafson2024,
  author = {Gustafson, Dakota and DiStefano, Peter V and Wang, Xue Fan and Wu, Ruilin and Ghaffari, Siavash and Ching, Crizza and Rathnakumar, Kumaragurubaran and Alibhai, Faisal and Syonov, Michal and Fitzpatrick, Jessica and Boudreau, Emilie and Lau, Cori and Galant, Natalie and Husain, Mansoor and Li, Ren-Ke and Lee, Warren L and Parekh, Rulan S and Monnier, Philippe P and Fish, Jason E},
  title = {Circulating small extracellular vesicles mediate vascular hyperpermeability in diabetes},
  journal = {Diabetologia},
  year = {2024},
  doi = {10.1007/s00125-024-06120-9}
}
Kostenlos starten →